CAT-12-106

N/A

Report date: 2025/01/26 17:42:05

Base Information

Drug NameCAT-12-106
Drug Alias Nameanti-CD-30 antibody drug conjugate (Catalent)CAT-12-106
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 inhibitors
TargetsTumor necrosis factor receptor superfamily member 8
Therapy Area/IndicationsHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatalent Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatalent Inc
Inactive CompaniesN/A
Active IndicationsHodgkin Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A